Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-05 Sale | 2020-08-07 4:48 pm | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 10,000 | $33 | $330,000 | 24,090 (Direct) | View |
| 2020-07-29 Sale | 2020-07-30 7:03 pm | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 10,000 | $30 | $300,000 | 34,090 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-23 Disposition | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:03 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 13,621 | $0 | 26,936 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-09 6:24 pm | N/A 2033-06-08 | Disc Medicine Inc. | IRON | GEMAYEL GEORGES Director | 7,136 | $0 | 7,136 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:01 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 10,179 | $0 | 23,494 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:14 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,882 | $0 | 13,315 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:14 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,882 | $0 | 13,315 (Direct) | View |
| 2022-12-29 Option Award | 2023-01-03 5:17 pm | N/A 2032-12-28 | Disc Medicine Inc. | IRON | GEMAYEL GEORGES Director | 7,000 | $0 | 7,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:22 pm | 2023-02-22 2032-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 10,729 | $0 | 20,162 (Direct) | View |
| 2022-02-19 Disposition | 2022-02-23 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 4,222 | $0 | 9,433 (Direct) | View |
| 2022-02-19 Option Award | 2022-02-23 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 4,222 | $0 | 9,433 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:04 pm | N/A 2032-01-02 | Gemini Therapeutics Inc. | GMTX | GEMAYEL GEORGES Executive Chair of the Board | 793,274 | $0 | 793,274 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-16 07:56 am | N/A 2031-11-14 | Gemini Therapeutics Inc. | GMTX | GEMAYEL GEORGES See Remarks | 40,759 | $0 | 40,759 (Direct) | View |
| 2021-04-29 Option Award | 2021-05-03 4:02 pm | N/A 2031-04-28 | Gemini Therapeutics Inc. | GMTX | GEMAYEL GEORGES Director | 45,466 | $0 | 45,466 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:48 pm | 2022-02-19 2031-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 11,587 | $0 | 16,798 (Direct) | View |
| 2020-10-01 Disposition | 2020-10-01 5:12 pm | N/A 2026-01-01 | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 94,152 | $0 | 0 (Direct) | View |
| 2020-08-05 Exercise | 2020-08-07 4:48 pm | N/A N/A | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 10,000 | $14.84 | 24,090 (Direct) | View |
| 2020-08-05 Exercise | 2020-08-07 4:48 pm | 2018-01-01 2026-01-01 | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 10,000 | $0 | 24,090 (Direct) | View |
| 2020-07-29 Exercise | 2020-07-30 7:03 pm | N/A N/A | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 10,000 | $14.84 | 34,090 (Direct) | View |
| 2020-07-29 Exercise | 2020-07-30 7:03 pm | 2017-01-01 2026-01-01 | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 10,000 | $0 | 34,090 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-24 5:46 pm | N/A 2030-06-23 | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 5:24 pm | 2021-02-21 2030-02-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 9,305 | $0 | 14,516 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 5:24 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 5,211 | $23.99 | 14,516 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:16 pm | N/A 2029-06-19 | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 25,000 | $0 | 39,090 (Direct) | View |
| 2019-06-20 Exercise | 2019-06-21 4:16 pm | N/A N/A | MOMENTA PHARMACEUTICALS INC | MNTA | GEMAYEL GEORGES Director | 4,356 | $0 | 39,090 (Direct) | View |